MediClin: Group sales increased by EUR 9.3 mill. or 3.6 % in the first half-year of 2014 – Group operating result improved by EUR 6.7 mill.

Offenburg, July 31, 2014 – MEDICLIN Aktiengesellschaft (MediClin) achieved Group sales of EUR 266.7 mill. (1 HY 2013: EUR 257.4 mill.) in the first half-year of 2014 thus being EUR 9.3 mill. or 3.6 % above the previous first half-year’s value. The occupancy rate of the Group rose to 87.2 % (1 HY 2013: 85.3 %) compared with the same period of the previous year.

Raw materials and consumables used were below the previous year’s value despite the sales increase; staff costs and other operating expenses increased proportionally less than sales.
Compared to the first half-year of 2013 the Group operating result improved by EUR 6.7 mill. from EUR -3.6 mill to EUR 3.1 mill. and the result after tax attributable to shareholders of MediClin AG by EUR 6.6 mill. from EUR -5.6 mill. to EUR 1.0 mill.

Sales and earnings development in both segments post-acute and acute are satisfying

Sales of the segments post-acute and acute were EUR 5.4 mill. (+3.7 %) respective EUR 4.1 mill. (+4.0 %) up against previous years’ values. Only sales of the nursing care business area decreased by EUR 0.2 mill. to EUR 6.5 mill. Due to higher sales and moderately increased expenses the result of the post-acute segment improved by EUR 5.0 mill. from EUR -2.5 mill. to EUR +2.5 mill. and of the acute segment by EUR 2.0 mill. to EUR 5.1 mill. compared to the same period of the previous year.

In the first half-year of 2014 EUR 9.4 mill. (gross) was invested in non-current assets (1 HY 2013: EUR 8.6 mill.). As of June 30, 2014 cash and cash equivalents were EUR 11.5 mill. (30.06.2013: EUR 9.7 mill.) and the equity ratio was 47.3 % (30.06.2013: 48.5 %).
In the first half-year of 2014 MediClin employed on average 6,386 employees, measured in full-time employees (1 HY 2013: 6,371 full-time employees).

If one compares the second quarter 2014 with the first quarter 2014 the post-acute segment posted further sales increases and result improvements in the second quarter of 2014. In line with expectations the acute segment could not reach the high sales figures of the first quarter 2014 leading to a lower segment result compared to the first quarter of 2014.

Outlook
Thanks to good business development of the first-half year of 2014 and the sales and earnings improvements that are expected on the back of the measures already initiated, the Management Board assumes that the target margins for both the Group and the segments will be reached in 2014.

The interim report as of June 30, 2014 will be available from August 8, 2014 under www.mediclin.de in German and English.

About MediClin AG (Ticker: MED; WKN: 659 510)

MediClin AG is a nation-wide clinic operator and large provider of services in the area of Psycho- and Neuro-sciences as well as Orthopaedic. With 34 clinics and 7 nursing care facilities and 10 medical care centres in 11 federal states MediClin has a total capacity of approximately 8,000 beds. MediClins’ facilities include acute care clinics, i.e., general hospitals, special treatment facilities, specialised hospitals and clinics for post-acute treatment and medical rehabilitation. MediClin has approximately 8,800 employees.
MediClin ─ a company of the Asklepios Group.